CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
Abstract Hepatocellular carcinoma (HCC) is a common malignancy in human. CD44 is a transmembrane glycoprotein which is frequently overexpressed in cancer of various origins. The function and mechanism of CD44 in HCC remains elusive. In this study, we reported that CD44 was overexpressed in HCC to pr...
Saved in:
Main Authors: | Jun Zhang, Xilin He, Yajie Wan, Honghong Zhang, Tao Tang, Meng Zhang, Shiyi Yu, Weiyong Zhao, Liming Chen |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a0f2cfa14d3a42d0b8233f2d622ff2b1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat
by: Zhang CL, et al.
Published: (2012) -
Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity
by: Shanshan Zhang, et al.
Published: (2021) -
A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
by: David MARKS, et al.
Published: (2021) -
MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
by: Lim EL, et al.
Published: (2013) -
Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
by: Bodiford A, et al.
Published: (2015)